vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $185.2M, roughly 1.5× AMICUS THERAPEUTICS, INC.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 0.9%, a 15.7% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 23.7%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $16.0M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 29.5%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
ALAB vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $185.2M |
| Net Profit | $45.0M | $1.7M |
| Gross Margin | 75.6% | 85.7% |
| Operating Margin | 24.7% | 8.6% |
| Net Margin | 16.6% | 0.9% |
| Revenue YoY | 91.8% | 23.7% |
| Net Profit YoY | 82.0% | -88.5% |
| EPS (diluted) | $0.25 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $185.2M | ||
| Q3 25 | $230.6M | $169.1M | ||
| Q2 25 | $191.9M | $154.7M | ||
| Q1 25 | $159.4M | $125.2M | ||
| Q4 24 | $141.1M | $149.7M | ||
| Q3 24 | $113.1M | $141.5M | ||
| Q2 24 | $76.8M | $126.7M | ||
| Q1 24 | $65.3M | $110.4M |
| Q4 25 | $45.0M | $1.7M | ||
| Q3 25 | $91.1M | $17.3M | ||
| Q2 25 | $51.2M | $-24.4M | ||
| Q1 25 | $31.8M | $-21.7M | ||
| Q4 24 | $24.7M | $14.7M | ||
| Q3 24 | $-7.6M | $-6.7M | ||
| Q2 24 | $-7.5M | $-15.7M | ||
| Q1 24 | $-93.0M | $-48.4M |
| Q4 25 | 75.6% | 85.7% | ||
| Q3 25 | 76.2% | 88.5% | ||
| Q2 25 | 75.8% | 90.2% | ||
| Q1 25 | 74.9% | 90.7% | ||
| Q4 24 | 74.0% | 90.1% | ||
| Q3 24 | 77.7% | 90.6% | ||
| Q2 24 | 77.9% | 91.1% | ||
| Q1 24 | 77.4% | 87.7% |
| Q4 25 | 24.7% | 8.6% | ||
| Q3 25 | 24.0% | 20.3% | ||
| Q2 25 | 20.7% | -6.1% | ||
| Q1 25 | 7.1% | -6.3% | ||
| Q4 24 | 0.1% | 10.7% | ||
| Q3 24 | -7.9% | 15.3% | ||
| Q2 24 | -31.7% | 11.8% | ||
| Q1 24 | -127.1% | -25.1% |
| Q4 25 | 16.6% | 0.9% | ||
| Q3 25 | 39.5% | 10.2% | ||
| Q2 25 | 26.7% | -15.8% | ||
| Q1 25 | 20.0% | -17.3% | ||
| Q4 24 | 17.5% | 9.8% | ||
| Q3 24 | -6.7% | -4.8% | ||
| Q2 24 | -9.8% | -12.4% | ||
| Q1 24 | -142.5% | -43.9% |
| Q4 25 | $0.25 | $0.00 | ||
| Q3 25 | $0.50 | $0.06 | ||
| Q2 25 | $0.29 | $-0.08 | ||
| Q1 25 | $0.18 | $-0.07 | ||
| Q4 24 | $1.23 | $0.05 | ||
| Q3 24 | $-0.05 | $-0.02 | ||
| Q2 24 | $-0.05 | $-0.05 | ||
| Q1 24 | $-1.77 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $1.4B | $274.2M |
| Total Assets | $1.5B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $293.5M | ||
| Q3 25 | $140.4M | $263.8M | ||
| Q2 25 | $162.3M | $231.0M | ||
| Q1 25 | $86.4M | $250.6M | ||
| Q4 24 | $79.6M | $249.9M | ||
| Q3 24 | $126.1M | $249.8M | ||
| Q2 24 | $421.1M | $260.1M | ||
| Q1 24 | $696.1M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $1.4B | $274.2M | ||
| Q3 25 | $1.3B | $230.4M | ||
| Q2 25 | $1.1B | $204.3M | ||
| Q1 25 | $1.0B | $193.6M | ||
| Q4 24 | $964.8M | $194.0M | ||
| Q3 24 | $889.6M | $178.8M | ||
| Q2 24 | $845.3M | $132.5M | ||
| Q1 24 | $808.8M | $130.7M |
| Q4 25 | $1.5B | $949.9M | ||
| Q3 25 | $1.4B | $868.8M | ||
| Q2 25 | $1.3B | $815.3M | ||
| Q1 25 | $1.1B | $789.8M | ||
| Q4 24 | $1.1B | $785.0M | ||
| Q3 24 | $983.1M | $786.6M | ||
| Q2 24 | $915.5M | $749.5M | ||
| Q1 24 | $864.9M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $16.3M |
| Free Cash FlowOCF − Capex | $76.6M | $16.0M |
| FCF MarginFCF / Revenue | 28.3% | 8.6% |
| Capex IntensityCapex / Revenue | 6.9% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.12× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $16.3M | ||
| Q3 25 | $78.2M | $35.7M | ||
| Q2 25 | $135.4M | $-26.5M | ||
| Q1 25 | $10.5M | $7.8M | ||
| Q4 24 | $39.7M | $-3.9M | ||
| Q3 24 | $63.5M | $-23.0M | ||
| Q2 24 | $29.8M | $22.7M | ||
| Q1 24 | $3.7M | $-29.7M |
| Q4 25 | $76.6M | $16.0M | ||
| Q3 25 | $65.9M | $35.3M | ||
| Q2 25 | $133.3M | $-28.9M | ||
| Q1 25 | $6.0M | $7.5M | ||
| Q4 24 | $24.3M | $-4.2M | ||
| Q3 24 | $46.8M | $-23.3M | ||
| Q2 24 | $28.5M | $21.6M | ||
| Q1 24 | $228.0K | $-31.5M |
| Q4 25 | 28.3% | 8.6% | ||
| Q3 25 | 28.6% | 20.9% | ||
| Q2 25 | 69.5% | -18.7% | ||
| Q1 25 | 3.7% | 6.0% | ||
| Q4 24 | 17.2% | -2.8% | ||
| Q3 24 | 41.4% | -16.5% | ||
| Q2 24 | 37.1% | 17.0% | ||
| Q1 24 | 0.3% | -28.5% |
| Q4 25 | 6.9% | 0.2% | ||
| Q3 25 | 5.3% | 0.2% | ||
| Q2 25 | 1.1% | 1.6% | ||
| Q1 25 | 2.8% | 0.2% | ||
| Q4 24 | 10.9% | 0.2% | ||
| Q3 24 | 14.8% | 0.3% | ||
| Q2 24 | 1.7% | 0.9% | ||
| Q1 24 | 5.2% | 1.6% |
| Q4 25 | 2.12× | 9.62× | ||
| Q3 25 | 0.86× | 2.06× | ||
| Q2 25 | 2.64× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 1.61× | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALAB
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
